Kyunghee Burkitt

Building frameworks for better understanding of cancer biology, Dr. Kyunghee Burkitt serves as an Assistant Professor at the University Hospitals Seidman Cancer Center and is an integral member of the Developmental Therapeutics Program at Case Comprehensive Cancer Center. With an M.D., Ph.D. degree and board certification in internal medicine, Dr. Burkitt is at the forefront of research in epigenetic modification and DNA damage response pathways. Her research is primarily centered on the development of novel therapies for head and neck cancer, aiming to enhance the efficacy of existing treatment modalities such as chemotherapy, radiation therapy, and immunotherapy. Dr. Burkitt's work is pivotal in understanding how epigenetic changes can influence cancer progression and treatment response, providing insights that could lead to more personalized and effective therapeutic strategies. In her clinical practice, Dr. Burkitt is dedicated to improving patient outcomes by integrating cutting-edge research findings into clinical protocols. Her approach involves a comprehensive evaluation of how genetic and epigenetic factors contribute to cancer resistance and sensitivity, thereby tailoring treatment plans to the unique genetic makeup of each patient. Dr. Burkitt's contributions to the field have been recognized through numerous publications and presentations at national and international conferences. Her commitment to advancing cancer treatment is reflected in her collaborative efforts with fellow researchers and clinicians, fostering an environment of innovation and discovery. Through her work, Dr. Burkitt continues to push the boundaries of cancer research, with the ultimate goal of translating scientific discoveries into tangible improvements in patient care. Her dedication to both research and clinical excellence makes her a valuable asset to the medical and scientific communities.